Growth Conundrum Confronts Quest and LabCorp
AFTER MORE THAN TWO DECADES of buying up almost every attractive laboratory asset that came up for sale—and with few lab acquisition candidates left to buy—Laboratory Corporation of America and Quest Diagnostics Incorporated find themselves in an interesting conundrum. As public companies, any increase in the value of their shares is directly linked to growth …
Growth Conundrum Confronts Quest and LabCorp Read More »